openPR Logo
Press release

Plasma Protease C1-inhibitor Treatment Market : Segmental Highlights and Table of Content (2017-2025)

12-11-2017 08:15 AM CET | Health & Medicine

Press release from: Transparency Market Research

Plasma Protease C1-inhibitor Treatment Market : Segmental

Global Plasma Protease C1-inhibitor Treatment Market: Players Focus on Expanding Product Portfolio to Expand Outreach, says TMR

A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are some other key vendors that hold significant shares in the overall market for plasma protease C1-inhibitor treatment.

According to estimations of the TMR report, the demand in the global plasma protease c1-inhibitor treatment market will expand at a strong 20.0% CAGR for the forecast period of 2017 to 2025, for the market to be evaluated at US$7.9 bn by 2025-end considerably up from its evaluated worth of US$1.5 bn in 2016. Key vendors in the plasma protease c1-inhibitor treatment market are engaged in expanding their product portfolio and expand their distribution networks in order to penetrate global markets. This has mandated vendors to meet the regulatory standards set by governing bodies at national and international level.

Report overview @ https://www.transparencymarketresearch.com/plasma-protease-c1inhibitor-treatment-market.html

The global Plasma Protease C1-inhibitor Treatment Market is segmented on the basis of Drug Class, Distribution Channel, end user and region.

In terms of drug class, the global plasma protease C1-inhibitor treatment market witness maximum demand from the segment of c1-inhibitors that led amongst other segments in 2016. Geography-wise, the report assesses North America to be the most profitable market for plasma protease c1-inhibitor treatment, which accounted for a demand worth US$1,510.5 mn in 2017.

Growing investment for innovation in inhibitor drugs, promising pipeline drugs and novel therapies, and increasing awareness for hereditary angioedema (HAE) are primarily driving the plasma protease C1-inhibitor market through 2025.

Request to sample report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33116

One of the key drivers of the plasma protease C1-inhibitor treatment market is the increasing usage of plasma protease C1-inhibitor treatment drugs due to the increasing incidence of acute cases of hereditary angioedema (HAE) and prophylaxis. The emergence of C1-inhibitor is considered to be a major breakthrough among several drugs introduced in the plasma protease C1-inhibitor treatment market. Berinert is a C1-esterase inhibitor for acute HAE that received approval from the European Union in 2011. Haegarda, which is derived from C1-esterase inhibitor is approved in the U.S for routine prophylaxis as a preventive measure against HAE attacks in adolescents and adults.

Increasing practice of administering prophylactic treatment process for HAE patient, demand for a new route of administration of C1-inhibitor drugs, rising demand for administering drugs subcutaneously among HAE patients are some other growth drivers of the plasma protease C1-inhibitor treatment market.

Apart from this, commercialization of drugs such as Ruconest in emerging markets of Asia Pacific is likely to boost the C1-inhibitor segment in the upcoming years.

Research studies underway for the development of bradykinin B2 receptor antagonist for the treatment of HAE attacks is likely to propel the global plasma protease C1-inhibitor treatment market. At present, Firazyr is the only approved bradykinin B2 receptor for the treatment of acute HAE attack. FR 173657 is another bradykinin B2 receptor that researchers are evaluating for efficacy for acute HAE attack.

Summary of Table of Content

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary : Global Plasma Protease C1-Inhibitor Treatment Market

4. Market Overview

5. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Drug Class

6. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Dosage Type

7. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Distribution Channel

8. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Region

9. North America Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

10. Europe Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

11. Latin America Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

12. Rest of World Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

13. Competition Landscape

14. Key Take Aways

Get full report now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=33116<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Protease C1-inhibitor Treatment Market : Segmental Highlights and Table of Content (2017-2025) here

News-ID: 853622 • Views: 2238

More Releases from Transparency Market Research

Medical Foods Market 2020 : Key Players, SWOT Analysis, Key Indicators, Forecast …
Medical Foods Market: Introduction According to the report, the global medical foods market was valued at US$ 18 Bn in 2018 and is projected to grow at a rapid pace from 2019 to 2027. Medical foods are a special group of FDA-regulated products that meet the distinctive dietary needs or metabolic defects of a medical illness. The current opinion among the public is that medical foods have the therapeutic potential to
Surgical Face Masks Market 2021 : Key Players, SWOT Analysis, Key Indicators, Fo …
Global Surgical Face Masks Market: Overview The products in the global surgical face masks market are disposable devices that create a barrier between the mouth and nose of the user and the pollutants present in the immediate surrounding of the user. These products in the global surgical face masks market have been used on a massive scale in the ongoing COVID-10 pandemic. The products in the global surgical face masks market
operating room equipment Market 2022 : Key Players, SWOT Analysis, Key Indicator …
The global operating room equipment market was valued at US$ 29,912.3 Mn in 2017. It is projected to expand at a CAGR of 6.4% from 2018 to 2026. Aging population and longer life-expectancy, increased awareness, and acceptance of advanced devices are likely to drive the operating room equipment market from 2018 to 2026. Access Full Report @ https://www.transparencymarketresearch.com/operating-room-equipment-market.html An operating room, also known as operation theatre, is a facility within a
skin care devices Market 2021 By Emerging Trends, Industry Share, Regional Overv …
Skincare Devices Market: Introduction According to the report, the global skincare devices market was valued at US$ 11.4 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028. Skincare devices are gaining importance not only because of extensive usage in aesthetics, but also due to increase in incidence of skin disorders globally. Skincare devices assist in efficient diagnosis and treatment of various skin conditions

All 5 Releases


More Releases for Plasma

Plasma Equipment Market Brief Analysis of Top Leading Companies From 2022-2028: …
The latest competent intelligence report published by WMR with the title "An increase in demand and Opportunities for Global Plasma Equipment Market 2022" provides a sorted image of the Plasma Equipment industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making a gradual impact on the global economy. The report
Contract Plasma Etching Market Incredible Possibilities, Growth With Industry St …
Contract Plasma Etching Market: A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Contract Plasma Etching Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report
Cold Plasma Market Size, Growth, and Key Manufacturers – SOFTAL Corona & Plasm …
Report Ocean releases its latest report on the global Cold Plasma Market. A combination of information gathered from first-hand sources, qualitative and quantitative assessments of industry analysts, and insights from experts and participants across the value chain is used to calculate the global Cold Plasma Market. The global cold plasma market was valued at US$1.5 billion in the year 2020, and is further anticipated to be worth US$7.9 billion by the
Plasma Equipment Market Growing Popularity and Emerging Trends | Plasma Air, Wel …
A New business Strategy report released by HTF MI with title Global Plasma Equipment Market Study Forecast till 2026 . This Global Plasma Equipment market report brings data for the estimated year 2020 and forecasted till 2026 in terms of both, value (US$ MN) and volume (MT). The report also consists of forecast factors, macroeconomic factors, and a market outlook of the Plasma Equipment market. The study is conducted by
Plasma Light Market: Pure Plasma Lighting, Lightahead, CozyCabin, RioRand, Cryst …
MarketResearchReports.Biz adds “Global Plasma Light Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Plasma Light market and the growth estimates for the forecasted period. This report studies the global Plasma Light market status and forecast, categorizes the global Plasma Light market size (value & volume) by key players, type, application, and region. This report focuses on the top
Plasma Equipment Market Trend to 2025 Profiling Plasma Air, Plasma etching techn …
The Plasma Equipment Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the Plasma Equipment industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. In this report, the global Plasma Equipment market value is provided for 2017 in million-dollar terms